Profile data is unavailable for this security.
About the company
Median Technologies SA is a France-based company that publishes software for the diagnosis and monitoring of cancer patients. The Company develops lesion management solutions (LMS) to objectively measure and track cancerous or suspicious lesions, distribute a standardized oncologic report and centralize the lesion information for multidisciplinary review. The LMS line includes such products as LMS-Lung, a clinical application for the detection, evaluation and follow-up of lesions identified in CT images covering the chest; LMS-Track, a clinical application for the follow-up of oncology patients; and LMS-Liver, a clinical application for the initial evaluation and the follow-up of liver metastases and any other lesions identified in CT images covering the liver. The Company operates one subsidiary, Median Technologies Inc, based in the United States.
- Revenue in EUR (TTM)22.23m
- Net income in EUR-22.98m
- Incorporated2002
- Employees242.00
- LocationMedian Technologies SALes Deux Arcs - Batiment B 1800Route des CretesVALBONNE 06560FranceFRA
- Phone+33 493333777
- Fax+33 492906599
- Websitehttps://mediantechnologies.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Laboratoires Euromedis SA | 34.04m | 13.11m | 15.58m | 54.00 | 1.18 | 0.6835 | 1.17 | 0.4578 | 4.60 | 4.60 | 11.66 | 7.93 | 0.6415 | 3.05 | 3.92 | 630,347.60 | 24.71 | 8.76 | 34.65 | 12.45 | 0.5338 | 15.57 | 38.52 | 6.10 | 1.46 | -26.38 | 0.3031 | -- | -37.18 | -- | 320.97 | -- | -- | -- |
Implanet SA | 7.30m | -6.91m | 15.75m | 41.00 | -- | 4.50 | -- | 2.16 | -0.1305 | -0.1226 | 0.0979 | 0.028 | 0.5227 | 0.7927 | 3.83 | 179,262.90 | -49.48 | -37.44 | -111.96 | -86.74 | 55.22 | 59.59 | -94.67 | -67.43 | 0.5906 | -14.51 | 0.5671 | -- | -7.24 | 2.08 | -88.59 | -- | -2.20 | -- |
Diagnostic Medical Systems SA | 42.15m | -9.76m | 16.58m | 147.00 | -- | 1.30 | -- | 0.3933 | -0.4982 | -0.2481 | 2.23 | 0.7023 | 0.8027 | 1.81 | 6.81 | 286,755.10 | -18.73 | -12.33 | -33.53 | -22.14 | 37.58 | 37.72 | -23.33 | -16.45 | 0.7105 | -3.52 | 0.5938 | -- | 19.51 | 11.62 | -106.30 | -- | -- | -- |
Ikonisys SA | 448.56k | -2.27m | 16.77m | 10.00 | -- | 0.9594 | -- | 37.38 | -0.233 | -0.233 | 0.0461 | 1.62 | 0.0211 | 1.18 | 32.21 | 44,856.00 | -10.65 | -- | -12.50 | -- | -20.88 | -- | -505.54 | -- | 0.0619 | -29.68 | 0.1244 | -- | -27.28 | -- | 7.38 | -- | -- | -- |
Theraclion SA | 1.82m | -3.68m | 19.21m | 29.00 | -- | 3.40 | -- | 10.54 | -0.0811 | -0.0811 | 0.0397 | 0.1236 | 0.1118 | 0.1081 | 0.6807 | 62,835.52 | -22.54 | -32.98 | -30.99 | -48.01 | 81.88 | 60.85 | -201.68 | -249.16 | 2.86 | -40.63 | 0.2564 | -- | 47.49 | -1.13 | 25.97 | -- | -7.23 | -- |
Mauna Kea Technologies SA | 10.48m | -3.73m | 21.93m | 68.00 | -- | -- | -- | 2.09 | -0.0578 | -0.0578 | 0.2126 | -0.2809 | 0.4905 | 2.31 | 2.45 | 154,117.60 | -17.45 | -51.23 | -223.84 | -93.30 | 33.62 | 11.15 | -35.57 | -142.41 | 0.4287 | 4.29 | 2.38 | -- | 40.13 | 9.16 | 66.66 | -- | -21.16 | -- |
Global Bioenergies SA | 486.33k | -7.36m | 23.51m | 46.00 | -- | -- | -- | 48.34 | -0.4036 | -0.4036 | 0.0267 | -0.0081 | 0.0276 | 2.74 | 0.1188 | 10,572.39 | -41.78 | -43.66 | -99.83 | -82.47 | -600.24 | -948.35 | -1,513.81 | -1,331.36 | 0.8447 | -- | -- | -- | 365.83 | 36.25 | 27.78 | -- | -19.49 | -- |
AbL Diagnostics SA | 5.61m | 54.36k | 45.77m | 19.00 | 842.73 | 6.76 | 63.87 | 8.15 | 0.0034 | 0.0034 | 0.3483 | 0.42 | 0.3703 | -- | 1.42 | 295,411.60 | 0.3587 | 3.24 | 0.5884 | 4.43 | -- | -- | 0.9685 | 8.81 | 1.87 | -47.51 | 0.3389 | -- | -35.84 | 74.86 | -95.08 | -49.30 | -- | -- |
Biosynex SA | 92.98m | -37.12m | 47.60m | 575.00 | -- | 0.3885 | -- | 0.512 | -3.64 | -3.64 | 9.10 | 11.92 | 0.3704 | 1.16 | 7.34 | 161,700.90 | -14.18 | 14.90 | -17.51 | 19.41 | 52.84 | 51.92 | -38.30 | 14.61 | 1.03 | -28.00 | 0.3459 | -- | -52.70 | 24.40 | -337.76 | -- | -- | -- |
Carmat SA | 5.53m | -53.35m | 51.81m | 162.00 | -- | -- | -- | 9.37 | -1.76 | -1.76 | 0.1787 | -0.6419 | 0.0932 | 1.61 | 1.28 | 30,379.12 | -89.92 | -76.92 | -113.71 | -94.38 | -535.50 | -- | -964.91 | -4,636.64 | 1.69 | -17.37 | 1.63 | -- | 710.72 | -- | -0.3502 | -- | 16.99 | -- |
Affluent Medical SAS | 0.00 | -17.04m | 70.02m | 66.00 | -- | 2.26 | -- | -- | -0.5338 | -0.5338 | 0.00 | 0.7864 | 0.00 | -- | -- | 0.00 | -28.43 | -- | -34.69 | -- | -- | -- | -- | -- | -- | -24.62 | 0.3586 | -- | -- | -- | -2.80 | -- | -- | -- |
Median Technologies SA | 22.23m | -22.98m | 75.91m | 242.00 | -- | -- | -- | 3.42 | -1.26 | -1.26 | 1.21 | -0.5608 | 0.6289 | -19.61 | 3.55 | 91,842.98 | -65.02 | -54.57 | -186.81 | -157.51 | 104.50 | 101.57 | -103.40 | -93.70 | 1.40 | -- | 2.21 | -- | -6.10 | 28.52 | -13.70 | -- | 38.38 | -- |
Holder | Shares | % Held |
---|---|---|
Herald Investment Management Ltd.as of 31 Dec 2023 | 522.35k | 2.84% |
Aguja Capital GmbHas of 30 Jun 2023 | 512.69k | 2.79% |
Apo Asset Management GmbHas of 30 Apr 2024 | 477.24k | 2.59% |
Financi�re Arbevel SAas of 30 Dec 2022 | 401.15k | 2.18% |
Discover Capital GmbHas of 31 Dec 2023 | 200.00k | 1.09% |
Montpensier Finance SASas of 29 Dec 2023 | 128.23k | 0.70% |
Mandarine Gestion SAas of 29 Feb 2024 | 115.00k | 0.63% |
Lonvia Capital SASUas of 31 Dec 2023 | 79.87k | 0.43% |
Cholet Dupont Asset Management SAas of 31 Dec 2023 | 76.23k | 0.41% |
Pure Capital SAas of 31 Dec 2023 | 68.29k | 0.37% |